Compare

Aethlon Medical Inc vs GeoVax Labs, Inc. vs OS Therapies Inc vs Ernexa Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAethlon Medical Inc
AEMD
GeoVax Labs, Inc.
GOVX
OS Therapies Inc
OSTX
Ernexa Therapeutics Inc.
ERNA
Year ended2026-03-312025-12-312025-12-312025-12-31
Revenuen/a$2.49Mn/an/a
Revenue growth (YoY)n/a-37.1%n/an/a
Gross marginn/an/an/an/a
Operating marginn/a-869.3%n/an/a
Net marginn/a-862.3%n/an/a
Net income-$7.15M-$21.46M-$28.75M-$14.08M
EPS (Diluted)-$10.61n/a-$0.98-$2.24
Operating cash flow-$7.00M-$21.47M-$14.24M-$7.02M
Free cash flow-$7.00M-$21.50M-$14.70M-$7.05M
Cash & equivalents$5.03M$3.09Mn/an/a
Total assets$6.33M$6.34M$6.84M$5.83M
Total liabilities$1.45M$2.52M$11.86M$3.43M
Shareholders' equity$4.89M$3.83M-$6.10M$2.40M
Return on year-end equity-146.4%-561.2%n/a-586.6%
Shares outstanding1.57M1.73M37.11M7.85M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAethlon Medical IncGeoVax Labs, Inc.OS Therapies IncErnexa Therapeutics Inc.
Latest$0
Ended 2024-03-31
$2.49M
Ended 2025-12-31
n/a$582.0K
Ended 2024-12-31
1 year earlier$574.2K
Ended 2023-03-31
$3.95M
Ended 2024-12-31
n/a$68.0K
Ended 2023-12-31
2 years earlier$294.2K
Ended 2022-03-31
$0
Ended 2023-12-31
n/a$0
Ended 2022-12-31
3 years earlier$659.1K
Ended 2021-03-31
$81.5K
Ended 2022-12-31
n/an/a
4 years earlier$650.2K
Ended 2020-03-31
$385.5K
Ended 2021-12-31
n/a$5.80M
Ended 2020-12-31